As a classically trained pharmacokineticist, Dr. Donavon McConn's expertise encompasses in vitro and in vivo drug metabolism, drug interactions, PK-PD, PB-PK modeling and translational research. Dr. McConn has been involved with over 25 IND/CTA submissions, numerous Phase I and PoC investigations and three marketed compounds.
Dr. McConn received a BS in chemistry from University of California, Davis and a Ph.D. in Pharmaceutics from the University of Washington.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.